Financial Support
Bill to expand financial support for living kidney donors progresses in Washington
Legislation that would expand eligibility for reimbursement of certain expenses related living organ donation passed the House and was introduced in the Senate, according to the website Congress.gov.
Mission Therapeutics receives $5.2M to advance novel small-molecule Parkinson’s therapy
Mission Therapeutics has been awarded $5.2 million from The Michael J. Fox Foundation for Parkinson’s Research and Parkinson’s UK to advance a selective, small molecule, brain penetrant USP30 inhibitor for Parkinson’s disease.
Study to assess remote screening for financial hardship in patients with cancer
The Patient-Centered Outcomes Research Institute awarded almost $10.5 million to Alliance NCTN Foundation to assess the value of remote digital screening for financial hardship to improve patient-centered outcomes in patients with cancer.
Guidelines aim to take financial advocacy ‘to the next step’
Association of Community Cancer Centers’ Financial Advocacy Network released consensus-based guidelines to help practices prevent, identify or mitigate financial hardships among their patients.
Rapport Therapeutics raises $150M in funding to advance neuromedicine platform
A clinical-stage biotechnology company announced that it has raised $150 million in funding to advance its neuromedicine platform.
Astrocyte Pharmaceuticals gets $6M to advance novel brain injury therapeutic
A Boston-area clinical stage drug discovery and development company announced $6 million in pre-Series B bridge financing to advance a novel cerebroprotectant therapeutic intended to treat a broad range of acute brain injuries.
US awards $11.4M for therapeutic to treat Fragile X-associated tremor
The U.S. Department of Defense has awarded $11.4 million to a Boston-based biotherapeutics firm to advance its novel oral prodrug of endogenous allopregananolone, LYT-300, to treat Fragile X-associated Tremor Ataxia syndrome.
Octave Bioscience gets $30M to advance MS, neurodegenerative treatment platform
A Bay Area-based precision care company has announced $30 million in funding to continue providing care for those with multiple sclerosis and other neurodegenerative diseases.
AltPep secures $53M in funding to advance novel Alzheimer’s, Parkinson’s therapeutics
A Seattle-based biotechnology company announced completion of a $52.9 million Series B financing round to advance clinical trials of novel therapeutics for Alzheimer’s and Parkinson’s diseases.
ElevateMeD seeks to advance physician workforce diversity through Scholars Program
The nonprofit organization ElevateMeD Inc. has announced its 2023-’24 Scholars Program cohort, a group of 25 underrepresented medical students from across the country who each will be awarded a $16,500 tuition-based scholarship.